Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2025-12-26 @ 1:40 AM
NCT ID:
NCT05972733
Pre Assignment Details:
Healthy volunteers were enrolled in 1 treatment arm and received a single dose of HIL-214, a norovirus vaccine comprising 50 µg GI.1 virus-like particle (VLP) and 150 µg GII.4c VLP, adjuvanted with 500 µg of aluminum hydroxide.
Recruitment Details:
Participants took part in the trial at 2 investigative sites in the United States from 01 August 2023 to 10 November 2023.
Study:
NCT05972733
Study Brief:
Results Section:
NCT05972733